ALSO NOTED: Advanced Magnetics touts Phase III data; MicroIslet makes staffing changes; and much more...

> Advanced Magnetics has announced preliminary positive results from its fourth and final planned Phase III clinical trial of ferumoxytol as an intravenous iron replacement therapeutic in chronic kidney disease patients. Release

> It's hard to decipher, but 'staffing changes' have been announced by MicroIslet in a new release. Release

> Depomed and Watson Pharmaceuticals have inked a deal to co-promote the extended-release version of Depomed's urinary tract infection treatment ProQuin. Release

And Finally… Roche's low-key recall of the AIDS drug Viracept has roiled the treatment of many of the world's poorest patients. Article